January 15, 2026 - 02:53

In a job market marked by unprecedented challenges, securing your dream position may seem daunting, but it remains achievable. This week, career coach and former Facebook executive AJ Mizes shared valuable insights on how to differentiate yourself as a candidate.
Mizes emphasizes the importance of adapting to the evolving landscape by incorporating artificial intelligence into your workflow. This not only enhances efficiency but also showcases your tech-savviness to potential employers. Moreover, he highlights strategies for making a successful career pivot, encouraging individuals to leverage transferable skills and experiences that align with their desired roles.
Crafting a compelling application is crucial in today's competitive environment. Mizes advises job seekers to thoroughly research the companies they are applying to and tailor their resumes and cover letters to reflect the organization's values and goals. By following these strategies, candidates can significantly improve their chances of standing out in a crowded job market and ultimately landing their ideal positions.
August 31, 2026 - 20:06
Fed Chairman Kevin Warsh warned about inflation — but that's not why long-term rates are surging: Chart of the DayThe recent jump in long-term borrowing costs has investors scratching their heads, especially since the Federal Reserve`s newest chairman, Kevin Warsh, keeps hammering on inflation. But the real...
August 31, 2026 - 00:01
Honda (HMC), Nissan Edge Toward a Software AllianceHonda Motor Co. Ltd. and Nissan Motor are reportedly nearing a deal to work together on vehicle software and onboard computer systems. According to Japan`s Nikkei newspaper, an agreement could be...
August 30, 2026 - 12:20
Laureate Education (LAUR) Looks Fairly Valued, Is There Enough Upside Left?Laureate Education (LAUR) has caught the eye of investors after the stock closed at US$38.80 on 26 August 2026. The recent trading pattern shows a slight cooling over the last day, but the broader...
August 29, 2026 - 22:05
AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?Investors looking at large-cap pharma in 2026 face a clear fork in the road. Eli Lilly has ridden the wave of metabolic drugs like Mounjaro and Zepbound to a stunning 45 percent revenue jump,...